Susan ALTSCHULLER - May 15, 2023 Form 3 Insider Report for Cerevel Therapeutics Holdings, Inc. (CERE)

Role
Chief Financial Officer
Signature
/s/ Mark Bodenrader, as Attorney-in-Fact
Stock symbol
CERE
Transactions as of
May 15, 2023
Transactions value $
$0
Form type
3
Date filed
5/19/2023, 04:15 PM
Previous filing
Dec 27, 2022
Next filing
Jun 5, 2023

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney